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The mouse PancChip, a microarray developed for studying endocrine pancreatic development and diabetes, represents over
13,000 cDNAs. After computationally assigning the cDNAs on the array to known genes, manual curation of the remaining sequences
identified 211 novel transcripts. In microarray experiments, we found that 196 of these transcripts were expressed in total pancreas and/or
pancreatic islets. Of 50 randomly selected clones from these 196 transcripts, 92% were confirmed as expressed by qRT-PCR. We evaluated
the coding potential of the novel transcripts and found that 74% of the clones had low coding potential. Since the transcripts may be partial
mRNAs, we examined their translated proteins for transmembrane or signal peptide domains and found that about 40 proteins had one of
these predicted domains. Interestingly, when we investigated the novel transcripts for their overlap with noncoding microRNAs, we found
that 1 of the novel transcripts overlapped a known microRNA gene.
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protein-coding mRNA genes is estimated to be around 30,000
[1]. After completion of the human, and later mouse, draft
genomes, genes were identified based on alignment of cDNAs
[2] and computational approaches that predict exons with
reasonable accuracy [3]. Additional genes present in genomes
are continually added from evidence including genome tiling
microarrays [4,5] and the sequencing of cDNA libraries [6,7].
Generally, these results indicate that the number of genes⁎ Corresponding author. Center for Bioinformatics, School of Medicine,
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doi:10.1016/j.ygeno.2006.04.005present in various mammalian genomes has been under-
estimated. These genes may be expressed in a tissue-restricted
manner and could be identified by data mining of tissue-based
cDNA libraries using their associated expressed sequence tags
(ESTs).
Fifteen mouse endocrine pancreas cDNA libraries were
constructed and sequenced by the Endocrine Pancreas Consor-
tium as part of an effort to identify novel transcripts expressed in
islet and pancreas tissues [8]. These libraries were found to be
enriched for transcripts expressed in the mammalian pancreas.
Each EST sequence, belonging to a cDNA clone from a
consortium library, was associated with a DoTS transcript (DT)
(http://www.allgenes.org). DTs are consensus RNAs created by
clustering and assembling ESTs and mRNA sequences from
dbEST and GenBank. By using the derived DoTS consensus
753J.M. Mazzarelli et al. / Genomics 88 (2006) 752–761sequence, it is often easier to identify the coding potential of a
cDNA from the pancreatic libraries, since a single EST
sequence may not have sufficient information content or length.
In addition, the similarity-based clustering of the consortium
library ESTs into DTs allowed for the derivation of a largely
nonredundant clone set that was used to construct the Mouse
PancChip, a pancreas-enriched cDNA microarray [8], designed
as a tool for studying changes in RNA expression in pancreas
and islet tissues [9].
To increase the value of information derived from experi-
ments using the PancChip, the transcripts on the chip were,
when possible, assigned an Entrez Gene identifier [10].
Automated annotation was also applied to all DTs containing
pancreas ESTs. Annotation included alignment to genomic
sequence, coding potential, and gene trap tag similarities [11].
The DoTS annotation supplements the information associated
with each cDNA clone on the PancChip. Some of the transcripts
on the PancChip could not be assigned to a particular Entrez
Gene. Here, we combined manual curation of these sequences
followed by expression analysis to classify these transcripts and
their genes. Using this approach, we were able to identify a
substantial number of new genes expressed in the islet and
pancreas.
Results
Identifying transcripts on the mouse PancChip
The mouse PancChip (version 5.0) is a pancreas-enriched
cDNA microarray [8]. Of the 13,008 cDNA clones on the
mouse PancChip, 94% have been sequence verified (Table 1).
To assign the ESTs represented on the chip to a particular gene,
the accessions were associated with Entrez Gene identifiers [10]
using multiple methods as described under Materials and
methods. Gene assignment was performed for only those clones
that passed sequence verification. The most frequently
occurring Entrez Gene ID for the cDNA clone, the “chosen”
Entrez Gene ID, was compared to the Entrez Gene ID found for
the clone using genomic sequence. If the gene identifiers were
identical, the Entrez Gene ID for the clone was considered
validated (Table 1). Ninety-three percent of the Entrez Gene IDs
assigned to cDNA clones on the PancChip were validated in thisTable 1
Annotation of the Mouse PancChip 5.0 cDNA clones
Number of clones on chip 13,008
Number of sequence-verified clones a 12,200
Number of clones assigned an Entrez Gene ID b 11,662
Number of clones assigned a verified Entrez Gene ID c 11,298
Number of clones not assigned an Entrez Gene ID d 902
a Sequence-verified clones for which attempts were made to assign an Entrez
Gene ID as described under Materials and methods.
b Assigned an Entrez Gene ID using the methods described under Materials
and methods.
c The Entrez Gene ID was verified using genomic sequence as described
under Materials and methods.
d Clones never assigned an Entrez Gene ID or the Entrez Gene ID assigned
was not verified.manner. Gene IDs were not assigned to clones if they were not
validated.
Identification of novel transcripts on the PancChip
The ESTs of 902 clones on the chip that were not assigned
validated Entrez Gene IDs were examined manually in the
context of their DTs, BLAT [12] aligned to genomic sequence,
and viewed as a custom track on the UCSC Genome Browser
[13]. The DTs for novel clones were classified as defining exons
of putative novel genes if the sequences did not overlap exons
of annotated genes as defined by RefSeq [14] and MGC [15]
and known genes based on SWISS-PROT, TrEMBL [16],
mRNAs, and RefSeqs [17] displayed on the browser. This
classification of novel clones includes DTs that align within
introns of annotated genes since these DTs would not overlap
exons of these genes but align within their introns. The DTs that
did overlap exons of known genes were manually associated
with the known gene. The novel cDNA clones were also
evaluated using sequence and/or feature evidence, which
included the following: spliced transcript (intron containing),
number of mRNAs or ESTs associated with the DT, orientation
(antisense or sense), presence of a putative 3′ polyadenylation
signal, conserved mRNA, conservation of genomic sequence,
and absence of repetitive elements. Using the sequence
evidence described above, 211 cDNA clones were classified
as novel clones. Fig. 1 is an example of a DT containing an EST
(CF586012) from a novel PancChip clone. The expression of
the clone (IMAGE 6430326) was greater in islet than in total
pancreas and was validated using both microarray analysis and
quantitative reverse transcription polymerase chain reaction
(qRT-PCR) (Table 2). Some of the novel clones were derived
from the same putative genes since their ESTs associated with
identical DTs. Since seven putative genes had two cDNA clones
associated with them, 204 of the 211 clones represented novel
genes.
Based upon their location within the introns of known genes,
DTs were also classified as defining potentially novel exons of
annotated genes or as defining novel genes that reside within
introns. In either case, these DTs aligned within the introns of
annotated (known) genes and did not overlap exons. A set of
154 clones had DTs that aligned within the introns of annotated
genes. An example is the DT containing an EST (BM053670)
from a novel clone that aligns within the intron of a known
gene, Pdpk1. The expression of the cDNA clone (IMAGE
5668133) in the pancreas was validated using both microarray
analysis and qRT-PCR (Table 2).
Expression of novel transcripts
To validate the set of 211 novel cDNA clones as expressed
transcripts, we examined their expression profiles in two-
channel microarray experiments comparing total pancreas
versus isolated pancreatic islets, which represent the endocrine
compartment of the pancreas. Pancreas and islet mRNAs were
isolated from five biological replicates each. The fluorescently
labeled cDNAs were used in 10 assays including “dye swaps,”
Fig. 1. An example of a DoTS transcript-containing EST (CF586012) from a novel PancChip clone. The cDNA clone (IMAGE 6430326) was more highly expressed
in the islet.
754 J.M. Mazzarelli et al. / Genomics 88 (2006) 752–761resulting in 20 channel measurements. An average of 85% of
the novel clones exceeded the threshold values for expression
(see Materials and methods) for the 20 channel measurements.
One hundred ninety-six of the 211 novel clones were considered
transcribed based on their mean signal exceeding the threshold
in 18 of the 20 channel measurements. Using the same criteria
for the 154 novel clones with sequences located within introns,
143 were considered expressed.
The expression data for the pancreas versus islet experiments
were also normalized using global loess (see Materials and
methods), and the 196 expressed clones were examined for their
differential expression in pancreas versus islet. Based upon the
normalized value (average of the five experiments), a small
fraction of the novel clones was expressed at higher levels in
islets (Fig. 2), whereas the majority were transcribed more
actively in the pancreas. This was also the case for the novel
clone sequences located within introns (not shown).
Expression of novel transcripts validated by qRT-PCR
Of the 196 novel clones, 50 novel cDNA clones were
randomly selected for qRT-PCR validation of their expression
(Table 2). Based upon their normalized expression values fromNotes to Table 2:
a The novel clone identifier. Note that insulin (Insl1) and amylase (Amy2) clones
b The fold change was calculated for the average of the normalized values; the f
(pancreas/islet), after separate global loess normalization.
c PaGE (Pattern from Gene Expression) confidence measure using a 10% false di
d Clones called as differently expressed based on the PaGE confidence measure a
e The qRT-PCR median cycle threshold (Ct) value. The value shown is the lowes
f Clones with a Ct less than 36 were considered expressed.
g qRT-PCR-calculated fold change (pancreas/islet).
h t test P value determined for the expression difference between pancreas and isl
i Differential expression determined by qRT-PCR based upon a p value significan
j Clones with greater expression in islet.
k Clones with a gene trap tag sequence similarity.the microarray study, three different classes of cDNA clones
were chosen randomly: those that had higher expression in islet,
those that had comparable expression in islet and pancreas, and
those that expressed at higher levels in total pancreas. Using a
threshold cutoff of 36 cycles (see Materials and methods), 46
clones (92%) were found to be expressed (Table 2). Of the 4
clones not considered expressed by qRT-PCR, 2 of the clones
had low signal intensities while the remaining 2 clones had a
cycle threshold greater than 36. For all 50 genes, qRT-PCR data
were normalized to a housekeeping gene, TBP or HPRT1, and
differential expression between pancreas and islet was deter-
mined. Because qRT-PCR is more sensitive than the microarray
approach, some discrepancy was apparent between the micro-
array and qRT-PCR data with respect to calling clones
differentially expressed. Of the 50 randomly chosen novel
clones, 25 were called as differentially expressed in the
microarray study using a 10% FDR (false discovery rate) and
a fold-change value greater than 1.5 (Table 2). Of these 25
differentially expressed genes, 21 were confirmed to have
differential expression by qRT-PCR, closely matching the
predicted FDR. In addition, of the other 25 genes not called as
differentially expressed on the microarray, 16 were found to be
differentially expressed by qRT-PCR, resulting in a total of 37were added for expression comparison.
ive normalized values represented dye-swap combinations: average of log2
scovery rate (FDR). Note that PaGE confidence = 1−FDR.
nd the normalized fold change (1.5-fold up or down).
t of the average Ct of five replicates for that gene in either pancreas or islet.
et.
ce cutoff of 0.05.
755J.M. Mazzarelli et al. / Genomics 88 (2006) 752–761differentially expressed genes. Of these, 14 were confirmed to
have enriched expression in the islet, while 23 had enriched
expression in the pancreas (P < 0.05) (Table 2). Taken together,Table 2
Expression analysis of 50 novel PancChip clones in the pancreas and islet using mi
Clone
ID a
(IMAGE
or
WASHU)
Microarray PancChip 5.0
Global loess
normalized
fold change b
PaGE
confidence c
Differentially expressed d Ct
value e
6432765
(Ins1)
−16.80 0.957 Yes 9.7
5668714 1.45 0.948 31.5
466628 −2.22 0.953 Yes 34.9
5682532 −8.28 0.964 Yes 33.7
6432716 −3.23 0.957 Yes 28.2
6431573 −4.72 0.957 Yes 32.1
6431250 −3.36 0.958 Yes 26.2
386963 −1.91 0.953 Yes 31.9
5939973 −3.43 0.957 Yes 23.8
6436002 1.22 0.833 29.0
5668728 4.26 0.948 Yes 33.7
5944587 1.27 0.948 25.1
6430326 −3.39 0.953 Yes 28.0
6433529 −1.01 0.865 31.6
5939006 −1.80 0.961 Yes 27.2
6433740 2.62 0.948 Yes 31.4
5682873 −1.29 0.953 39.6
6435582 −1.06 0.942 30.9
6436095 −1.04 0 29.4
637305 −3.71 0.953 Yes 24.2
6433640 −1.01 0.69 40.0
5668721 −1.49 0.947 28.7
ie22h08 −1.79 0.953 Yes 28.4
574676 −1.04 0.121 26.9
5668133 2.23 0.948 Yes 19.8
6433944 1.03 0.636 37.0
6435976 −1.08 0.901 37.0
5679153 1.17 0.764 32.5
423070 1.07 0.953 34.0
6430324 23.92 0.948 Yes 27.2
6436590 −1.34 0.953 33.3
6431176 1.01 0 26.2
5945432 3.61 0.948 Yes 24.2
6435987 1.02 0.924 35.6
6434225 1.80 0.948 Yes 28.2
ie22c03 1.17 0.948 24.6
6437114 3.51 0.948 Yes 32.7
6435823 −1.01 0.953 35.7
5944210 1.08 0.764 33.8
5669109 −1.06 0.949 33.3
483016 4.59 0.948 Yes 25.7
6435475 3.25 0.948 Yes 35.6
5682170 −1.22 0.952 35.3
5656460 3.05 0.948 Yes 29.0
6436205 1.11 0.612 34.8
5946000 −2.20 0.962 Yes 34.4
5678475 1.18 0.065 34.2
6435524 7.16 0.948 Yes 32.0
5945860 8.69 0.948 Yes 32.0
6433618 1.95 0.948 Yes 27.5
6437091 2.30 0.846 27.3
5678870
(Amy2)
13.36 0.948 Yes 7.0these results indicate the likelihood that the remaining 146 novel
clones also represent genes expressed (and differentially
expressed) in pancreas and islets.croarray and qRT-PCR
qRT-PCR Gene trap
tag k
Expressed f Fold
change g
t test h Significantly
differentially
expressed i
Enriched in
islets j
Yes −55.87 0.0000 Yes Yes
Yes −21.93 0.0001 Yes Yes Yes
Yes −10.45 0.0000 Yes Yes
Yes −8.65 0.0000 Yes Yes
Yes −7.91 0.0000 Yes Yes
Yes −7.56 0.0000 Yes Yes
Yes −5.99 0.0012 Yes Yes
Yes −4.66 0.0004 Yes Yes
Yes −4.64 0.0009 Yes Yes
Yes −4.04 0.0028 Yes Yes Yes
Yes −3.76 0.0357 Yes Yes
Yes −3.47 0.0279 Yes Yes
Yes −3.44 0.0003 Yes Yes Yes
Yes −2.87 0.0126 Yes Yes Yes
Yes −2.14 0.0036 Yes Yes Yes
Yes −2.67 0.0840
−1.69 0.2933
Yes −1.28 0.5722
Yes −1.15 0.4000 Yes
Yes −1.01 0.9799 Yes
1.00 0.0001
Yes 1.04 0.8777 Yes
Yes 1.20 0.4008 Yes
Yes 1.32 0.3103 Yes
Yes 1.47 0.2603 Yes
2.00 0.1362
2.59 0.0514
Yes 4.05 0.1952 Yes
Yes 2.88 0.0003 Yes Yes
Yes 2.98 0.0094 Yes
Yes 3.70 0.0081 Yes
Yes 3.83 0.0001 Yes
Yes 4.00 0.0002 Yes
Yes 4.24 0.0015 Yes
Yes 4.31 0.0008 Yes
Yes 4.53 0.0011 Yes
Yes 4.98 0.0389 Yes
Yes 5.67 0.0014 Yes
Yes 6.82 0.0001 Yes
Yes 13.49 0.0004 Yes
Yes 15.08 0.0101 Yes
Yes 16.43 0.0000 Yes
Yes 20.20 0.0000 Yes
Yes 20.92 0.0002 Yes
Yes 27.83 0.0039 Yes
Yes 29.81 0.0000 Yes
Yes 31.96 0.0000 Yes
Yes 41.50 0.0009 Yes
Yes 58.97 0.0000 Yes
Yes 146.02 0.0010 Yes
Yes 190.68 0.0000 Yes
Yes 32.36 0.0000 Yes
Fig. 2. Normalized expression of each novel cDNA clone from the pancreas versus islet microarray experiments. The normalized expression value is the average of the
five experiments. The values represent dye-swap combinations: average of log2(pancreas/islets), after separate global loess normalization.
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similarities
Gene trap tags are generated from the insertion of a
reporter gene into an endogenous gene with the resulting
fused RNA transcript providing a sequence tag for the gene
[11]. DTs were assigned gene trap tags by determining the
genomic overlap of a sequence tag and a DT. Gene trap tags
were obtained from GenBank, originating from eight separate
sources (see Materials and methods), and BLAT aligned to
genomic sequence. Forty-one novel cDNA clones had DT
transcripts that overlapped gene trap tags, providing addition-
al evidence that these genes are indeed transcribed. Thirteen
of these clones were included in the previously described
analysis, and all were confirmed as expressed in either
pancreas or islet (Table 2). The DTs for novel intronic clones
were also examined for their overlap with gene trap tags.
There were 34 novel intronic cDNA clones that had DTs
overlapping gene trap tags.
Coding potential of novel transcripts
As part of the DoTS transcript annotation pipeline, protein
similarities for DTs are determined using BLASTX [18] against
the nonredundant protein database (NRDB) maintained by
NCBI. If there is a protein similarity with a probability value of
less than 1 × 10−5, then this protein similarity is associated with
the DT. Of the 275 DTs (average length 837 bp, median length
555 bp) associated with the 196 novel clones described above,
74% had no protein similarities. As discussed under Materials
and methods, it is possible to have more than one DT associated
with a clone. Two hundred seventy-five DTs were associated
with the 196 novel clones and were used for this analysis
because part of the utility of using DoTS, as mentioned under
Discussion, is that sufficient overlap of ESTs or mRNAs will
extend the EST sequence creating a longer transcript. The 275
DTs were also examined for protein domain similarities usingProDom and the Conserved Domain Database (CDD). Only 59
of the 275 DTs associated with the novel clones had a protein
domain similarity, and in most cases, the description of the
domain was not informative enough to assign a protein function
to the translated transcript. For the 204 DTs (average length
698 bp, median length 528 bp) that reside within introns of
known genes, 48% of these had no protein similarities.
The DTs containing the novel PancChip ESTs were also
examined for their coding potential using the Framefinder [19]
translation program. A p value was associated with the DT
corresponding to the likelihood of the open reading frame given
the transcript length based on chance. The average p value for
the DTs associated with the novel clones was 0.66 (median
0.83), which suggests that many of the DTs had low coding
potential. Of the 275 DTs containing the novel EST sequences,
26 transcripts had a p < 0.05 and therefore maybe protein
coding. While the average length for known mouse proteins is
420 amino acids [20], the average length of the predicted
proteins was 81 amino acids. For the DTs residing within
annotated introns, the average p value was 0.64 (median 0.81)
and the average length 72 amino acids.
There are two possibilities why a DT might have poor
coding potential. First, the DT might correspond to a
noncoding RNA gene, or second, it may be a partial transcript
that lacks most or all of the open reading frame of a protein-
coding gene. Since the Pancreas Consortium libraries were
constructed using mRNA polyadenosine tract-directed cDNA
cloning technology, the DTs could represent 3′ UTR regions
of protein coding transcripts, although noncoding RNAs can
be polyadenylated as well [21]. Fig. 3 shows DTs having low
coding potential (p values about 0.7) but overlapping
conserved genomic sequences. The expression of the cDNA
clone (IMAGE 5939973) associated with these DTs was 4.6-
fold higher in islet cells when determined by qRT-PCR (Table
2). The fact that this transcript is differentially expressed and
well conserved supports our proposal that this DT is part of a
novel gene.
Fig. 3. DoTS transcripts DT.97358309 and DT.97381047 have low protein-coding potential, but overlap conserved genomic sequence. The DTs are associated with
IMAGE clone 5939973.
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expressed novel transcripts using their predicted peptide
sequences, we examined their amino acid sequences for
transmembrane regions and signal peptides using the algo-
rithms TMHMM2 [22] and SignalP [23], respectively.
Translated DTs were annotated for these protein features
using both algorithms as a step in the DoTS annotation
pipeline. For the signal peptide predictions, since the DTs may
represent partial transcripts, the signal peptide prediction may
not define the N-terminus of a translated protein. Thirty-seven
novel clones had one or more predicted transmembrane regions
while 42 clones had predicted signal peptides. The cDNA
clone (IMAGE 6431250) contained a predicted signal peptide
and two predicted transmembrane regions. The expression of
the cDNA clone was sixfold higher in islet cells as validated by
qRT-PCR (Table 2).Fig. 4. A 5′ EST (BI319615) from a novel PancChip IMAGE 6435524 clone is anti
clone.Novel DoTS transcripts overlap mouse microRNA genes
There are an increasing number of genes being identified
that generate noncoding RNA transcripts that are polyadeny-
lated and expressed in a tissue-specific manner [24]. Some of
these noncoding RNAs produce microRNAs, targeting
mRNAs for degradation or causing translational repression
[25]. Recently, specific microRNAs were cloned from
pancreatic cell lines [26]. When microRNAs were aligned
to the genome, microRNA genes were found within the
introns of protein-coding genes and in both the introns and
the exons of noncoding RNAs [27]. We examined 211 known
mouse microRNA genes, obtained from the MicroRNA
Registry (release 5) [28], for their overlap with the 275
DTs containing the novel PancChip ESTs. Using the BLAT
alignment of the DTs, we found that DT.94204759 overlappedsense to a microRNA (mmu-mir-299) gene. EST BI499991 is the 3′ EST of the
Table 3
Novel cDNA clones with DoTS transcripts that aligned within Idd (insulin-
dependent diabetes) loci
Locus a Chr b Clone ID c Expression d Fold change e
Idd10 3 5939162 1.03 2.04
Idd9.1 4 6435987 f 0.03 1.02
Idd9.1 4 5944749 0.75 1.69
Idd9.2 4 5668714 g 0.54 1.45
Idd9.2 4 5669279 1.03 2.04
a Idd locus identifier.
b Mouse chromosome.
c Clone ID corresponds to IMAGE clone ID.
d Expression is the average of five normalized values.
e Calculated fold change based upon averaged normalized value.
f Fold change for this clone also determined by qRT-PCR (4.24-fold).
g Fold change for this clone also determined by qRT-PCR (−21.93-fold).
758 J.M. Mazzarelli et al. / Genomics 88 (2006) 752–761a microRNA gene (mmu-mir-299) expressed in embryonic
stem cells [29], located within a cluster of microRNA genes
on mouse chromosome 12 (Fig. 4). Interestingly, the EST
overlapped the microRNA gene in an antisense orientation.
Strikingly, the cDNA clone (IMAGE 6435524) had 41.5-fold
higher expression in the pancreas compared to purified
pancreatic islets (Table 2).
Novel transcripts are located within insulin-dependent diabetes
(Idd) mouse loci
The nonobese diabetic (NOD) inbred mouse [30] is a
model for human insulin-dependent diabetes. Genetic anal-
ysis of the NOD mouse has established that the phenotype is
polygenically controlled by genomic regions referred to as
Idd loci, distributed over different chromosomes [31]. We
examined if DTs associated with the novel PancChip cDNA
clones were located within the genomic coordinates for nine
mouse Idd loci: Idd5.1, Idd5.2, Idd3, Idd10, Idd17, Idd18,
Idd9.1, Idd9.2, and Idd9.3 [32]. Table 3 shows five cDNA
clones that have DTs that align within three different Idd
loci. Four of these clones have higher expression in
pancreas, while one has higher expression in islet as
measured by qRT-PCR.
Discussion
Based upon recent expression analyses [4,5], it is becoming
increasingly apparent that the number of transcribed loci is
greater than first surmised. We have used DoTS transcripts from
the Database of Transcribed Sequences (http://www.allgenes.
org) to annotate transcripts expressed in the pancreas. Since
known genes or transcripts such as RefSeqs may have
incomplete 5′ and/or 3′ UTR regions, ESTs may represent
additional exons or extensions of these regions. On genomic
sequence, the alignment of these ESTs proximal to a known
gene may further substantiate this. An advantage of using DoTS
is that if there is sufficient overlap of a PancChip EST with an
mRNA, the 5′ or 3′ EST, when used to make a consensus DT,
will extend the UTR region of the transcript, associating the
ESTwith the known gene. When possible, the PancChip cDNAclones were assigned to known genes, and the remaining cDNA
clones were evaluated manually to classify them as known
transcripts or novel. We also have used DT annotation to
characterize the novel transcripts further, e.g., their coding
potential.
Using manual curation and microarray expression analysis,
we have identified 196 novel transcripts expressed in the islet
and pancreas corresponding to 189 putative genes and have
validated the expression of 46 (92% of a random sampling of 50
genes) of these genes by qRT-PCR. We have found that 37
clones are highly differentially expressed (ranging from 2- to
190-fold) between islet and pancreas. Of particular interest are
the 14 novel transcripts expressed higher in islet since their
genes could have important functions in the insulin-secreting β
cells of the islet.
Because genes may encode proteins or noncoding RNAs, we
examined the novel transcripts for both protein similarities and
coding potential. We found that many had no known protein
similarities and low coding potential, suggesting that the
transcripts are either noncoding RNAs or UTRs. To obtain
functional information for transcripts having predicted proteins,
we examined the proteins for the presence of signal peptides and
transmembrane regions and found that 42 transcripts had
predicted signal peptides while 37 had predicted transmembrane
regions.
It is becoming widely accepted that noncoding RNAs are
expressed to regulate cellular processes, and transcription of
these RNAs accounts for a significant amount of transcription in
genomes [24]. MicroRNAs are a class of noncoding RNAs that
regulate gene expression by an antisense mechanism causing
repression of mRNA translation [25], and several have been
cloned from islet cell lines [26]. Indeed, one of the cloned
microRNAs was found to target an mRNA for a protein
involved in glucose-induced insulin secretion [26]. We
examined if the novel transcripts overlapped known microRNA
genes and found that only one transcript overlapped a
microRNA gene. As more microRNAs become available at
the MicroRNA Registry [28], it is possible that additional novel
transcripts may overlap these new microRNAs, perhaps
representing their precursor microRNA transcripts. Analysis
of EST databases has identified precursor microRNAs,
belonging to known microRNAs, within a population of ESTs
[33]. Interestingly, the novel transcript that overlapped the
known microRNA gene overlapped in an antisense orientation,
suggesting that it could have a regulatory role in microRNA
expression.
The NOD mouse [30] is an animal model of insulin-
dependent diabetes, an autoimmune disorder that results from
the T-cell-mediated destruction of the insulin-producing β cells
in the pancreas. Genetic analysis has provided evidence of Idd
loci, distributed over different chromosomes, and current efforts
involve identifying the candidate genes within these regions
[31]. We have found that five novel transcripts align within
three Idd loci. Four of these transcripts have higher expression
in pancreas, while one has higher expression in islets as
measured by qRT-PCR, thereby adding to the number of
candidate genes to be considered.
759J.M. Mazzarelli et al. / Genomics 88 (2006) 752–761All methods of EST annotation have their strengths and
weaknesses, and here we have described a combined compu-
tational approach that we believe effectively overcomes the
weaknesses of an individual database approach. This method
for annotation provided an alternative way of reliably
annotating clones and can be easily adopted by other users of
cDNA arrays to ensure accurate annotation of their array.
Furthermore, the analysis described in this paper has highlight-
ed an approach used to discover new genes expressed in the
islets and pancreas. For these novel cDNA clones, further
experimentation is required to isolate their full-length cDNAs,
possibly identifying their entire open reading frames. This
would allow for their inclusion in transcript databases such as
NCBI's RefSeq, requiring a complete open reading frame. A
Web site, EPConDB, http://www.cbil.upenn.edu/EPConDB/,
for researchers in diabetes, β cell function, and pancreatic
development, provides access to expression profiles and
annotation for microarray studies performed using the mouse
PancChip, including the islet versus pancreas microarray
studies described here. In conclusion, we have shown that
careful annotation of pancreas-derived ESTs combined with
expression analysis has resulted in the identification of novel
genes.
Materials and methods
Computational annotation of the mouse PancChip
Entrez Gene IDs [10] were assigned to the cDNA clones on the mouse
PancChip using three methods. (1) Using mouse DoTS build version 10 (http://
www.allgenes.org), each cDNA clone was assigned one or two DoTS transcripts
using the DoTS database since their ESTs were clustered and assembled during
the build process. Since there are two ESTs associated with each clone (usually a
5′ and 3′ sequence), it is possible that the two sequences do not map to the same
DT, particularly if there is no input sequence(s) used in creating the consensus
that overlaps both ESTs. For each DT, the following three assignments were
obtained based on the DoTS annotation, Entrez Gene ID [10], MGI ID [34], and
RefSeq accession [14]. Fifty-six percent of the DTs in the database were
assigned directly an Entrez Gene ID. For those that did not have an Entrez Gene
ID, but had either a MGI ID or a RefSeq accession, these identifiers were used to
associate the DT with an Entrez Gene ID using two external files,
MGI_EntrezGene.rpt and gene2refseq.gz, available from the MGI and NCBI
download sites, respectively. This provided a mapping of EST accession to
Entrez Gene ID using the DT. (2) The PancChip EST accessions were annotated
using the UniGene database [35]. This was done by associating each EST
accession to a UniGene cluster using the Mm.gb_cid_lid file available from the
NCBI download site. Subsequently, the UniGene cluster ID was mapped to
Entrez Gene IDs using the gene2unigene file. This provided a mapping of EST
accession to Entrez Gene ID using the UniGene cluster. (3) Using the 5′ and 3′
ESTs of the PancChip clones, BLAST was performed against mouse RefSeqs
and RNAs were assigned to genes by MGI. For each EST, the top BLAST hit (p
value cutoff 10−15) was returned, and the Entrez Gene ID for the RNA was
assigned to the accession.
Using the three methods described above, the most common Entrez Gene
ID assigned to each accession or the “chosen” Entrez Gene ID was
determined. For chosen gene ID validation, the analysis performed compared
the chosen gene IDs for the accessions versus the Entrez Gene IDs assigned
to them based on their genomic location, i.e., where the genomic coordinates
of the accession overlapped the coordinates of RefSeqs or mRNAs aligned to
genomic sequence. The mRNA (or RefSeq) and the accession had to align to
the same mouse chromosome and strand of the genome. The BLAT alignment
coordinates for the mRNAs, RefSeqs, and EST accessions were obtained from
the UCSC download site (mouse May 2004) [36]. The file with the accessioncoordinates was filtered for the PancChip EST accessions. The RefSeqs and
mRNAs had Entrez Gene IDs assigned to them, and the accession, because of
the genomic overlap, was given the corresponding “genomic” Entrez Gene
ID. The RefSeqs and mRNA Entrez Gene IDs were obtained from the files
refLink.txt (UCSC download site) and gene2accession.gz (NCBI ftp site). If
the chosen gene ID agreed with the genomic gene ID, the Entrez Gene ID for
the clone was considered validated.
Manual annotation
For those PancChip 5.0 clones for which there was no computational
assignment of an Entrez Gene ID, we evaluated the location of the DT
containing the PancChip ESTs with respect to known genes as defined by
RefSeq [14], MGC [15], or SPTR [16] alignments displayed on the UCSC
Genome Browser (mouse version May 2004). PancChip cDNA clones were
classified as either putative novel transcripts or transcripts that align within an
intron of a known gene when their DTs did not overlap exons of known genes.
The GenBank EST and mRNA tracks provided evidence validating a novel DT.
This included the number of mouse mRNAs or ESTs used in creating the DTand
if the ESTs were frommultiple tissue libraries. Feature evidence for the gene was
obtained using the sequence alignment of DTs, defining splice sites of introns
(GT–AG) or putative 3′ polyadenylation signals (AATAAA or ATTAAA).
Additional annotation tracks on the UCSC browser that were used in evaluating
the novel DTs as conserved sequences and likely functional were nonmouse
mRNA and ESTs having sequence similarity, Rat/Human/Dog/Chicken Multiz
Alignments, and PhyloHMM Conservation. DTs consisting solely of genomic
repeats were excluded using the Repeating Elements by RepeatMasker (http://
ftp.genome.washington.edu/RM/RepeatMasker.html) and Simple Tandem
Repeats by Tandem Repeats Finder [37] tracks on the browser. Additional
details regarding the manual annotation process are included in the
supplementary materials.
Sample preparation and microarray expression analysis of the
pancreas and islet
Both pancreas and islet samples were isolated from adult CD1 mice as
described previously [38]. RNA was prepared from the isolated tissue using
the RNeasy procedure (Qiagen). All RNA samples were analyzed using an
Agilent Bioanalyzer Lab-on-a-Chip Nano 6000 chip to determine the
integrity and concentration of the samples. Only samples passing this
quality control step were used for expression analysis. In total, five
biological replicates of pancreas and five biological replicates of isolated
islets were used for expression analysis.
For each sample, 200 ng of total RNAwas amplified using the MessageAmp
aRNA kit (Ambion). The quality of the amplified RNA (aRNA) was also
evaluated using the bioanalyzer. Two micrograms of aRNA was labeled using
amino-allyl dUTP and random hexamers to prime reverse transcription. The
fluorescent label was coupled to the cDNA and subsequently hybridized to the
mouse PancChip, version 5.0 [8]. For each array hybridization a dye-swap
hybridization was performed, such that for each sample pairing, one
hybridization was performed as islet (Cy5: red) vs pancreas (Cy3: green) and
then repeated as pancreas (Cy5) vs islet (Cy3). With five biological replicates,
this dye-swap hybridization gave a total of 10 hybridizations. In doing this
replicate dye-swap analysis we reduced any impact that dye bias or other
labeling artifacts could have on the ratio of gene expression.
To determine which novel clones were expressed, a threshold value for the
20 channel measurements was obtained utilizing the foreground mean values for
896 blanks on the mouse PancChip. The 90th percentile of the foreground mean
signals (without background subtraction) for the blank spots was the threshold
for determining whether a cDNAwas expressed. If expression of a transcript was
above the threshold for that channel measurement then the clone was considered
“present,” if below the value, “absent.”
The median intensities of each spot on the array were measured by an
Agilent scanner using the GenePix version 5 software, and the ratio of
expression for each element on the array was calculated in terms ofM [log2(red/
green)] and A [(log2(red) + log2(green))/2)]. Data were normalized using print
tip loess normalization with the “marray” microarray analysis package in “R”
760 J.M. Mazzarelli et al. / Genomics 88 (2006) 752–761[39]. After normalization, the averageM value was calculated for each dye swap
and these data were deposited into the MIAME-compliant database, RAD [40].
For statistical analysis, genes were called differentially expressed using the
Pattern from Gene Expression package (PaGE version 5.0) as described
previously [41]. A two-class, unpaired data test was performed to identify
specifically genes that were differentially expressed in pancreas vs islet. An
FDR of 10% was chosen and only those genes with a fold change greater than
1.5 were identified as being significantly differentially expressed. Previous
studies have demonstrated that the combination of PaGE with this fold change
cutoff is an accurate predictor of true differential expression [42].
Quantitative RT-PCR validation
Differential gene expression was confirmed using qRT-PCR. PCR mixes
were assembled using the Brilliant SYBR Green qRT-PCR Master Mix
(Stratagene, La Jolla, CA, USA), 150 nM primers, and the included
reference dye ROX at a 1:30,000 dilution according to the manufacturer's
instructions. Reactions were performed using the SYBR Green (with
Dissociation Curve) program on the Mx3000 Multiplex Quantitative PCR
System (Stratagene). Cycling parameters were 95°C for 10 min and then 40
cycles of 95°C (30 s), 58 or 60°C (1 min), and 72°C (30 s) followed by a
melting curve analysis. All reactions were performed with five biological
replicates and three technical replicates with reference dye normalization.
The median cycle threshold (Ct) value was used for analysis, and all Ct
values were normalized to expression of the housekeeping gene TBP or
HPRT1. Primer sequences are available upon request. As both the pancreas
and the islets represent heterogeneous populations of cells, a gene being
expressed at at least one copy per 100 cells was set as our threshold for
expression. In the present study this was determined to be a threshold of 36
cycles, thus any gene with a Ct value of less than 36 cycles was considered
to be expressed, whereas if the Ct fell at 36 cycles or above the gene was
considered not to be expressed. To verify differential expression between
islet and pancreas, the Student t test was used to confirm that the
expression difference as determined by qRT-PCR was significant and
matched the direction of the fold change predicted by the array. An
unpaired t test using the two-tailed probability table with a p value
significance cutoff of 0.05 was used for all genes tested.
DoTS transcripts computational annotation
An annotation workflow containing WU BLASTX was applied to the
DTs generating computational annotation. The annotation pipeline was
composed of BLASTX similarity queries against the NRDB and the
ProDom motif database. These BLAST queries were run on a compute
cluster of Linux machines using the command line parameters W = 3,
T = 1000, wordmask = seg + xnu and the results were stored if the sum
value of the resulting hit was less than 1 × 10−5. The rpsBLAST algorithm
was also used to compare all consensus sequences against the CDD using
the default parameters. Descriptions were assigned to the DoTS consensus
sequences automatically by computing the percentage identity and
percentage coverage of the NRDB hit with the lowest p value. In cases
with identical p values, the longest match at that p value was used.
For eachDT, a translation using Framefinder [19] was generated. If the length
of a trivial translation (translated ORF from six possible) was three times the
length of the Framefinder translation, the trivial translation was used. A p value
was associated with the DT corresponding to the coding potential of the open
reading frame versus the protein length (V. Babenko and C. Stoeckert Jr.,
unpublished results). Putative transmembrane regions were predicted for the
translated proteins using the TMHMM2 algorithm [22]. Signal peptides were
predicted using the SignalP algorithm [23]. A supplementary data file containing
the transmembrane and signal peptide predictions for the clones was included.
DTs were BLAT aligned to the mouse genome (NCBI build 33) (Y.T. Gan et al.,
manuscript in preparation).
Gene trap tag sequences were obtained from GenBank and originated from
seven public sources including BayGenomics (http://baygenomics.ucsf.edu/),
GGTC (German Gene Trap Consortium, http://tikus.gsf.de/), MFGC (Mam-
malian Functional Genomics Center, http://www.escells.ca/), CMHD (Centerfor Modeling Human Diseases, http://www.cmhd.ca/), SIGTR (Sanger Institute
Gene Trap Resource, http://www.sanger.ac.uk/PostGenomics/genetrap/), the
Soriano [43] and Ruley labs [44], and Lexicon Genetics Inc. (http://www.
lexicon-genetics.com). The sequences were aligned to the mouse mm5 (NCBI
build 33) genome using BLAT [12] with a minimum percentage identity of 95%
over at least 10% of the tag length. A score calculated as the square root
of the product of the tag percentage and percentage identity (SQRT(%tag ×
%identity)) was used to assess alignment quality. A threshold score (80) was
determined using the alignment of a manually selected set of gene trap tags.
Tags with scores over the threshold that aligned to a single genomic location
over the entire genome were considered. The genomic coordinates of the
PancChip DTs were compared with the genomic coordinates of the filtered
gene trap tags to discover overlapping alignments.
The genomic coordinates of the PancChip DTs were compared with the
genomic coordinates of microRNA genes from the MicroRNA Registry (release
5) [28], obtained from the UCSC download site (mouse May 2004), to discover
overlapping alignments. The genomic coordinates of the PancChip DTs were
also compared with the genomic coordinates for the nine mouse Idd loci
obtained from the Type 1 Diabetes database, T1DBase [32], to find the DTs that
were located within these genomic regions.
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